Drugmaker raises price of old chemo drug tenfold; Republican ideas to reform Medicare

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages By Ed Silverman Adobe "I don’t see any evidence... to justify a 10-fold” price increase, said Stephen Schondelmeyer of the University of Minnesota. Read More STAT+: Republican ideas to reform Medicare could rile health care industry By Rachel Cohrs Kevin Dietsch/Getty Images Republicans' ideas to reform the Medicare program could draw opposition from powerful health care industry interests. Read More Listen: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT's Sarah Owermohle shares how shutdowns, vaccines, and the prospect of arresting Fauci have become midterm campaign rallying cries. Read More Sponsored Insight by Allucent CMC is a critical building block for product quality throughout the drug development process Chemistry, Manufacturing, and Controls (CMC) is the connection between the drug used in clinical studies and the drug that is marketed commercially and made available to consumers. The execution of an appropriately defined CMC product development strategy is vital to the success of your drug development program. In this blog from Allucent, learn about the benefits of engaging a CMC expert in your product development process from understanding regulatory requirements to marketing approvals. Learn more. 'If I were a hospital, I'd be reading the tea leaves': Pressures grow on the health care industry to reduce its climate pollution By Karen Pennar Christine Kao/STAT While hospitals might seem to be the unwitting victims of climate disasters, the U.S. health care system shoulders a good deal of the blame. Read More Thursday, October 27, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser